SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-013516
Filing Date
2021-07-15
Accepted
2021-07-15 17:37:43
Documents
2
Period of Report
2021-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3422
2 mattpoa.htm EX-24 9243
  Complete submission text file 0001567619-21-013516.txt   14018
Mailing Address 3101 WESTERN AVENUE, SUITE 600 SEATTLE WA 98121
Business Address
Plunkett Matthew (Reporting) CIK: 0001557551 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40604 | Film No.: 211093539

Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 904080 650 325 5156
Imago BioSciences, Inc. (Issuer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1214
SIC: 2834 Pharmaceutical Preparations